Mingshun Li
About Mingshun Li
Mingshun Li is a Senior Director at Bristol Myers Squibb, specializing in global drug development in the field of Immuno-oncology. He has extensive experience in the pharmaceutical industry, having previously worked at Pfizer Pharmaceuticals and AstraZeneca.
Company
Mingshun Li is currently employed at Bristol Myers Squibb, a global biopharmaceutical company headquartered in Princeton, New Jersey, United States. He holds the position of Senior Director at the company.
Title
Mingshun Li serves as Senior Director at Bristol Myers Squibb. Within this capacity, he is the Medical Director on the Immuno-oncology drug development team.
Experience at Pfizer Pharmaceuticals
From 2006 to 2011, Mingshun Li worked at Pfizer Pharmaceuticals as the Japan clinical leader. During his five-year tenure at the company, he was responsible for overseeing clinical operations within Japan.
Experience at AstraZeneca
Mingshun Li worked at AstraZeneca as a Clinical Research Associate (CRA) from 2005 to 2006. His tenure at AstraZeneca lasted for 11 months, during which he contributed to the clinical research team.
Education and Expertise
Mingshun Li holds a Ph.D. in Neurology from Tokyo Medical and Dental University, where he studied from 1998 to 2003. Additionally, he holds an MD in Medical Studies from Yanbian University, where he completed his studies from 1988 to 1993. His educational background provides a robust foundation in medical and neurological sciences.
Role in Immuno-oncology Drug Development
At Bristol-Myers Squibb, Mingshun Li is responsible for global drug development in the field of Immuno-oncology. His current role as Medical Director within the Immuno-oncology drug development team involves managing and directing efforts to advance treatments in this critical area of healthcare.